New large-capacity bioprocessing centrifuge enhances productivity and reliability
Thermo Scientific Sorvall BIOS 16 centrifuge designed to provide simplified, flexible bioprocessing.
Designed to maximize productivity for bioprocessing customers, the new Thermo Scientific Sorvall BIOS 16 centrifuge offers an increased capacity of up to 16 liters of cell culture product per run and unique design features to make working with large volumes easier and more convenient.
In the increasingly complex, regulated and fast-paced bioprocessing environment, users require a centrifuge with simple operation and high-throughput capabilities that deliver run-to-run reproducibility while maintaining sample integrity. These elements are essential to manufacturing products in a scalable, consistent and safe manner. In the development and manufacturing of biological products, centrifuges that support separation and purification processes are typically larger and are used continuously. Therefore, users put a high priority on ergonomically designed platforms.
The Thermo Scientific Sorvall BIOS 16 centrifuge includes several features designed to enhance the user experience, including
“For more than 60 years, Thermo Fisher Scientific has demonstrated application expertise across its centrifuge systems, and the addition of the Sorvall BIOS 16 bioprocessing centrifuge builds upon that commitment to delivering innovative designs to meet specific user needs,” said Monica Manotas, vice president and general manager, growth, protection and separation products at Thermo Fisher Scientific. “Now, bioprocessing centers around the world can reap the benefits of this unique, user-friendly system designed to provide high-throughput sample processing, simple, quick set-up and remote monitoring, energy savings, compliance with global safety standards and enhanced ergonomics with every run.”
The new Sorvall BIOS 16 bioprocessing centrifuge offers the flexibility to select higher-capacity rotors or match existing workflows, with a choice of four swinging bucket rotors ranging from 6 x 1000 mL to 8 x 2000 mL. This product is listed with the FDA and complies with the latest global safety standards including UL and CE.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance